Your session is about to expire
← Back to Search
Naltrexone for Social Connection
Study Summary
This trial is testing the effect of naltrexone, an opioid antagonist, on social connection. It is a randomized, placebo-controlled design, meaning that participants are assigned to either take naltrexone or a placebo (a "sugar pill" with no active ingredient) for 7 days. The participants will complete reports of their feelings of social connection and mood each day, and will also complete a physical symptoms questionnaire. On the 7th day, participants will come to the SDSU MRI scanning facility to complete tasks designed to elicit feelings of social connection in the fMRI scanner.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am in good health overall.I regularly take prescription medication.I am currently taking opioid painkillers.
- Group 1: Naltrexone
- Group 2: placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are elderly individuals being accepted into this clinical exploration?
"As per the requirements for this study, participants ought to be between 18 and 25 years of age."
What other research projects have utilized Naltrexone Hydrochloride as a focus?
"Currently, 45 trials actively researching Naltrexone Hydrochloride exist with 12 of them in the third phase. Most research is conducted within New york City, however there are a total of 160 sites that have studies running on this drug."
What medical conditions does Naltrexone Hydrochloride typically seek to address?
"Naltrexone Hydrochloride is regularly prescribed for long-term weight control therapies. In addition, it has been used to reduce pain and increase physical activity when combined with a reduced-calorie diet."
How many individuals are eligible to participate in this trial?
"Affirmative. The clinical trial website confirms that this research study is currently enrolling participants. It was initially posted on November 16th 2021 and its most recent update occurred on March 9th 2022, with the aim of selecting 210 participants from a single medical facility."
Are there any available openings in this clinical study?
"According to clinicaltrials.gov, this research is open for recruitment. Originally posted on November 16th 2021 and most recently amended on March 9th 2022, the experiment requires participants."
Are there certain individuals that are more suitable for this medical study?
"To meet the criteria for this trial, individuals must be aged between 18 and 25 years old and have access to naltrexone. This research is looking at recruiting a cohort of 210 people."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger